OnKure Therapeutics, Inc.
Pharmaceutical company · Boulder, Colorado, United States · Nasdaq: OKUR
OnKure Therapeutics, Inc. is a pharmaceutical company headquartered in Boulder, Colorado, United States. Its earliest recorded incorporation is in 2014. Its shares trade on Nasdaq under the ticker OKUR. It has reported private securities offerings to the US SEC, most recently $65 million sold in a notice filed in 2024.
OnKure Therapeutics at a glance
What does OnKure Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $65 million sold (2024).
Frequently asked questions about OnKure Therapeutics
Where is OnKure Therapeutics headquartered?
OnKure Therapeutics, Inc. is headquartered in Boulder, Colorado, United States.
What does OnKure Therapeutics do?
OnKure Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is OnKure Therapeutics a public company?
Yes. OnKure Therapeutics, Inc. trades on Nasdaq under the ticker OKUR.
When was OnKure Therapeutics founded?
The earliest incorporation on record for OnKure Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Edgewise Therapeutics, Inc.Boulder, Colorado, United States
- Clovis Oncology, Inc.Boulder, Colorado, United States
- Array Biopharma IncBoulder, Colorado, United States
- OnKure, Inc.Boulder, Colorado, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences